عنوان مقاله :
تعيين اثرات انالاپريل و لوزارتان بر روي آسيب DNA سلولي در بيماران پيوند كليه اي با پلي مورفيسم هاي سيستم رنين - آنژيوتانسين
عنوان به زبان ديگر :
The Effects of Enalapril and Losartan on DNA Damage in Renal
Transplant Recipients with Regarding to Renin-Angiotensin
System Polymorphisms
پديد آورندگان :
ويسي، پگاه نويسنده دانشگاه علوم پزشكي تبريز VEISI, P , قرباني حق جو، امير نويسنده دانشكده پيراپزشكي- مركز تحقيقات بيوتكنولوژي،دانشگاه علوم پزشكي تبريز Ghorbani Haghjoo, A. , ارگاني، حسن نويسنده دانشكده پزشكي- دانشگاه علوم پزشكي شهيد بهشتي تهران ARGANI, H , آقايي شهسواري، محمد نويسنده دانشگاه علوم پزشكي تبريز AGHAEISHAHSAVARI, M , نوروزيان اول، مسعود نويسنده دانشگاه علوم پزشكي تبريز NOROOZIANAVVAL , M , رشتچي زاده، نادره نويسنده دانشگاه علوم پزشكي تبريز Rashtchizadeh , N , صفا، جاويد نويسنده دانشكده پزشكي- دانشگاه پزشكي تبريز SAFA, J , مسگري، مهران نويسنده مركز تحقيقات كاربردي دارويي تبريز Mesgari , M
اطلاعات موجودي :
فصلنامه سال 1387
كليدواژه :
انالاپريل , آسيب DNA سلولي , پلي مورفيسم هاي سيستم رنين - آنژيوتانسين , پيوند كليه , لوزارتان
چكيده لاتين :
Background and Objectives: Oxidative injury of DNA and lipids may be supervised by
renin-angiotensin system (RAS). In the study the effect of losartan (L) and/or enalapril (E) on
reduction of DNA damage was evaluated regarding to renin-angiotensin system polymorphisms.
Materials and Methods: After determination of genotypes of the angiotensin converting
enzyme (ACE I/D), angiotensinogen (AGT M235T) and angiotensin II type 1 receptor (ATR1
A1166C) by polymerase chain reaction, 64 renal transplant recipients randomly allocated to one
of the four groups: first (13 patients) and second (20 patients) groups were treated with E (E+:
10mg/d) and L (L+: 50 mg/d) alone respectively. The third group (13 patients) as positive
control received E+L (E+L+: 10mg/d + 50 mg/d) and the forth group (22 cases) received no
medication as negative control (E-L-). The subjects were followed for 8 weeks. After 2 weeks
washout period, E group changed to L and vice versa as cross-over design. They were followed
for another 8 weeks. Before and after 2 months treatment, we checked the serum 8-OHdG and
Malondialdehyde (MDA) as biomarkers of DNA damage and lipid peroxidation respectively.
Results: Serum 8-OHdG levels were significantly decreased in the E+L+ and L+ groups
(6.07±1.1 ng/ml to 3.6±0.58 ng/ml, P=0.000; 5.30±0.86 ng/ml to 3.6±0.47 ng/ml, P=0.001
respectively). 8-OHdG level was not decreased significantly in E+ group (6±1.19 ng/ml to
4.7±1.39 ng/ml, P=0.07) and E-L- group (5.30±0.84 to 5.6±0.88 ng/ml, P=0.11). Patients with
DD genotype of ACE and CC genotype of ATR1 had higher serum 8-OHdG levels at the
basline (P=0.02, P=0.002 respectively). Only TT genotype of AGT had the most antioxidative
role regarding to kind of above treatment regimens (P=0.01). We found a remarkable correlation
between MDA and DNA damage levels before and after intervention (r=0.48, P=0.000; r=0.35,
P=0.006).
Conclusion: Although serum 8-OHdG level is higher in DD and CC genotypes of ACE and
ATR1 polymorphisms; the protective effects of L+ and E+L+ on DNA breaks are surprising
regarding to the RAS genotypes. TT genotype of AGT had important role in prevention of DNA
break regarding to kind of treatment
عنوان نشريه :
مجله پزشكي- دانشگاه علوم پزشكي و خدمات بهداشتي درماني تبريز
عنوان نشريه :
مجله پزشكي- دانشگاه علوم پزشكي و خدمات بهداشتي درماني تبريز
اطلاعات موجودي :
فصلنامه با شماره پیاپی سال 1387
كلمات كليدي :
#تست#آزمون###امتحان